[ad_1]
Teva Pharmaceutical Industries Ltd is recalling certain combinations of valsartan, a medicine for high blood pressure, as a result of the discovery of an impurity causing cancer, the latest recall of the drug in the world.
The Israeli pharmaceutical group will remember all lots of amlodipine-valsartan and amlodipine-valsartan-hydrochlorothiazide combination tablets due to an impurity in an ingredient manufactured by a Mylan unit based in India said Tuesday the FDA (Food and Drug Administration). (http://bit.ly/2DOBSfu)
Last week, the European Union effectively banned the sale of valsartan by the Mylan India unit after the discovery of certain batches containing the same impurity, N-nitrosodiethylamine.
Teva has not received any reports of adverse events signaling a potential link or exposure to valsartan, said the health regulator.
Patients are advised to continue taking their medications as the risk of harm may be higher if treatment is discontinued immediately without comparable treatment, the FDA said.
To read more, click here.
Source link
